SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UnitedHealth Group is trending sharply lower following the government's proposal for an unexpectedly minimal increase in 2027 Medicare Advantage payment rates, sparking broad concerns across the health insurance sector. While many view the significant sell-off as an overreaction and a long-term buying opportunity due to strong fundamentals, others anticipate further declines, highlighting policy risk and the ongoing political scrutiny on healthcare profitability.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

SPDR Gold Shares (GLD) is trending due to its recent surge to new all-time highs, fueled by increasing geopolitical instability, a depreciating US Dollar, and heightened central bank demand for physical gold. The community is sharply divided, debating whether this parabolic move is a legitimate hedge against fiat currency debasement or a speculative 'mania' ripe for a significant pullback.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN's recent upward trend is driven by strong community speculation regarding an upcoming Amazon Web Services (AWS) deal, with many anticipating a major announcement around the February 5th earnings. As a significant AI data center play, the stock is benefiting from its substantial Microsoft contract and general bullish sentiment in the AI infrastructure sector. While many traders are optimistic about new highs and potential short squeezes, some are watchful of market dips for accumulation and the stock's correlation with Bitcoin volatility.

Richtech Robotics, Inc. engages in the development of robotics and artificial intelligence. The firm designs, manufactures, and sells robots to restaurants, hotels, senior living centers, casinos, factories, and movie theaters. Its robots perform a variety of services including restaurant running and bussing, hotel room service delivery, floor scrubbing and vacuuming, and beverage and food preparation. The company was founded by Zhen Wu Huang and Zhen Qiang Huang on July 19, 2016 and is headquartered in Las Vegas, NV.

Richtech Robotics Inc. - Ordinary Shares - Class B

Richtech Robotics Inc.

Richtech Robotics ($RR) is capturing significant attention following its collaboration with Microsoft's AI Co-Innovation Labs to integrate advanced agentic AI into its ADAM robot, highlighting a pivotal development in the robotics sector. The community is actively discussing the potential for a sustained rally and short squeeze, though some express skepticism about the full impact of the partnership on the company's valuation.

GRI Bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapies for inflammatory, fibrotic, and autoimmune diseases. It focuses on its lead program, GRI-0621, an inhibitor of type 1 invariant Natural Killer T (iNKT) cell activity and is being developed as a novel oral therapeutic for the treatment of idiopathic pulmonary fibrosis. The company was founded by Vipin Kumar Chaturvedi in May 2009 and is headquartered in La Jolla, CA.

GRI Bio Inc

GRI Bio Inc. is actively trending following its recent 1-for-28 reverse stock split, which has created an exceptionally low float of approximately 500k shares. This development, coupled with recently announced positive Phase 2a clinical data and secured funding, is driving intense community discussion: many anticipate a significant short squeeze comparing it to prior low-float runners, while others express deep skepticism citing the company's history of frequent dilutions and management's perceived lack of trustworthiness.

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

iShares Silver Trust (SLV) is a major talking point as strong physical demand from global governments and industries like AI and EVs drives its significant rally, exacerbated by a weaker dollar. Community members are fiercely divided, with bulls anticipating a historic short squeeze due to supply deficits and alleged manipulation, while bears warn of an unsustainable bubble poised for a sharp correction.

TeraWulf, Inc. owns and operates fully integrated environmentally clean bitcoin mining facilities in the United States. TeraWulf will generate domestically produced bitcoin powered by nuclear, hydro and solar energy. The company was founded by Paul Prager and Nazar Khan on February 8, 2021 and is headquartered in Easton, MD.

TeraWulf Inc

TeraWulf is trending amid growing community excitement fueled by recent institutional interest, including a notable ownership stake by Bank of Nova Scotia and increased ETF allocations. Investors are eagerly anticipating significant "contract news" for its high-performance computing (HPC) data centers, hoping to see the company re-rated as a pure-play AI infrastructure provider rather than solely a Bitcoin miner. This anticipation is driving discussions around its potential to lead in the energy-intensive computing sector.

Seagate Technology Holdings Plc operates as holding company that is engaged in the development, production, and distribution of data storage products and electronic data storage solutions. Its products include hard disk drives, solid state hybrid drives, solid state drives, peripheral component interconnect express cards, serial advanced technology attachment controllers, storage subsystems and computing solutions. The firm offers its products under the Backup Plus and Expansion product lines, and Maxtor and LaCie brands. The company was founded in 1978 and is headquartered in Fremont, CA.

Seagate Technology Holdings Plc

Seagate Technology is actively trending after reporting a strong beat on revenue and EPS for its recent fiscal quarter, coupled with record gross margins and robust data center demand, specifically for its HAMR-based Mozaic products. While many in the community acknowledge the impressive results, some conversation centers on whether this strong performance was already anticipated, leading to mixed reactions post-report. This outcome further highlights the broader bullish narrative within the memory and data storage sector, driven by increasing AI infrastructure investments and sustained demand.

Cipher Mining, Inc. operates as a Bitcoin mining ecosystem in the United States. The firm is developing a cryptocurrency business. The company was founded in 2021 and is headquartered in New York, NY.

Cipher Mining Inc

Cipher Mining is generating significant buzz following analyst endorsements recognizing its AI/HPC colocation strategy and major contracts with hyperscalers. The community highlights strong institutional interest and buying pressure, viewing the stock as increasingly driven by its data center expansion rather than solely by Bitcoin's fluctuations, with many anticipating substantial upside.

Texas Instruments Incorporated engages in the design and manufacture of semiconductors. It operates through the following segments: Analog, Embedded Processing, and Other. The Analog segment semiconductors change real-world signals, such as sound, temperature, pressure or images, by conditioning them, amplifying them and often converting them to a stream of digital data that can be processed by other semiconductors, such as embedded processors. The Embedded Processing segment involves handling specific tasks and can be optimized for various combinations of performance, power, and cost, depending on the application. The company was founded in 1930 and is headquartered in Dallas, TX.

Texas Instruments Inc.

Texas Instruments (TXN) is actively discussed following its recent earnings, which reported misses on revenue and EPS alongside a conservative outlook. Despite these mixed results, the stock experienced an unexpected rally, prompting community speculation about a potential short squeeze defying the underlying financial data. This situation highlights a broader divergence between immediate performance challenges in industrial and automotive markets and long-term optimism surrounding the company's strategic investments in new manufacturing capabilities.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Lipocine Announces Completion of Enrollment and Dosing in Phase 3 Trial of LPCN 1154 in Postpartum Depression (PPD)

Lipocine Announces Completion of Enrollment and Dosing in Phase 3 Trial of LPCN 1154 in Postpartum Depression (PPD) Lipocine Announces Completion of Enrollment and Dosing in Phase 3 Trial of LPCN...

Lipocine Inc. (NASDAQ:LPCN) Short Interest Update

Lipocine Inc. (NASDAQ:LPCN - Get Free Report) was the recipient of a large increase in short interest in the month of December. As of December 31st, there was short interest totaling 157,602 shares...

Lipocine Reports Encouraging Progress Post Second Interim Safety Review in Phase 3 Trial of LPCN 1154 in Postpartum Depression (PPD)

Lipocine Reports Encouraging Progress Post Second Interim Safety Review in Phase 3 Trial of LPCN 1154 in Postpartum Depression (PPD) Lipocine Reports Encouraging Progress Post Second Interim Safety...

Lipocine's PPD Phase 3 Study (LPCN 1154) Hits 80% Enrollment Milestone

Lipocine's PPD Phase 3 Study (LPCN 1154) Hits 80% Enrollment Milestone Lipocine's PPD Phase 3 Study (LPCN 1154) Hits 80% Enrollment Milestone PR Newswire SALT LAKE CITY, Dec. 16, 2025 Second Drug...

Lipocine Highlights Promising Interim Safety Profile in Phase 3 Trial of LPCN 1154 in Postpartum Depression (PPD)

Lipocine Highlights Promising Interim Safety Profile in Phase 3 Trial of LPCN 1154 in Postpartum Depression (PPD) Lipocine Highlights Promising Interim Safety Profile in Phase 3 Trial of LPCN 1154 in...

Lipocine (LPCN) Reports Q3 Loss, Tops Revenue Estimates

Lipocine (LPCN) delivered earnings and revenue surprises of -5.36% and +15.00%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Lipocine Announces Financial Results for the Third Quarter Ended September 30, 2025

Lipocine Announces Financial Results for the Third Quarter Ended September 30, 2025 Lipocine Announces Financial Results for the Third Quarter Ended September 30, 2025 PR Newswire SALT LAKE CITY...

Lipocine Presents LPCN 2401 Clinical Data at ObesityWeek

Lipocine Presents LPCN 2401 Clinical Data at ObesityWeek Lipocine Presents LPCN 2401 Clinical Data at ObesityWeek PR Newswire SALT LAKE CITY, Nov. 4, 2025 SALT LAKE CITY, Nov. 4, 2025 /PRNewswire...

Lipocine, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of the delivery of drugs using proprietary delivery technology. It offers TLANDO, an oral testosterone replacement therapy. The company was founded on October 13, 2011 and is headquartered in Salt Lake City, UT.

LPCN
Lipocine Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest LPCN News

LPCNLipocine Inc